Company / Operating Income
BioLife Solutions, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$16.6M
FY2025
5-year range
-$35.2M / -$4.5M
FY2021-FY2025
Trend
-270.8%
vs FY2024
Sector context
#106 of 151
Health Care
What the data says
Operating Income changed -271% YoY in FY2025, a notable deviation from the 9-year average annual change of -367%.
Based on SEC 10-K filings.
-$17M in FY2025.
Improved from -$17M to -$17M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 151 in Health CareTop 70% of 151This company -$16.6M Sector average $716.7M
▼
-102.3% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 270.8% year-over-year.
- Ranks #106 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2018.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.6M | -270.8% |
| FY2024 | -$4.5M | +74.0% |
| FY2023 | -$17.2M | -190.5% |
| FY2022 | -$5.9M | +83.2% |
| FY2021 | -$35.2M | -463.4% |
| FY2020 | -$6.2M | -2736.8% |
| FY2019 | -$220.0K | -115.4% |
| FY2018 | $1.4M | +234.8% |
| FY2017 | -$1.1M | +78.2% |
| FY2016 | -$4.9M | +3.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026